Genky DrugStores Co., Ltd.

9267.T
Pharmaceutical Retailers
2026/08/24 Updated
Market Cap: $704.4M (¥112.2B)
Stock Price: $23.11 (¥3,680)
Exchange Rate: 1 USD = ¥159.24

FY June 2026 Q3 Earnings Presentation Materials

For the third quarter of FY June 2026, net sales were 52,449 million yen (YoY +7.9%), and operating income was 2,304 million yen (YoY +2.7%), nearly in line with the plan.

Importance:
Page Updated: April 28, 2026
IR Disclosure Date: April 28, 2026

Key Figures

  • Net Sales (Q3 Results): 52,449 million yen (YoY +7.9%)
  • Operating Income (Q3 Results): 2,304 million yen (YoY +2.7%)
  • Full-year Net Sales Forecast: 221,200 million yen (YoY +10.2%)

AI要約

Overview of Performance

For the third quarter of FY June 2026, net sales amounted to 52,449 million yen (YoY +7.9%) and operating income was 2,304 million yen (YoY +2.7%). Sales fell short of the plan by approximately 0.8%, but operating income reached the planned level. Same-store sales improved toward the latter half of Q3, with customer traffic steadily increasing by +1.5% YoY. Gross profit margin was almost on plan with a slight 0.1 point decrease compared to the plan. Selling, general and administrative expenses increased due to higher personnel and utility costs, but were contained by stable operation of self-checkout registers and a work transfer system.

Outlook and Plans

Full-year earnings forecast projects net sales of 221,200 million yen (YoY +10.2%) and operating income of 11,050 million yen (YoY +14.4%). Three new large-scale stores are planned to open during the fiscal year, with eight closures. The company aims to enhance profitability by balancing gross profit margin and SG&A expenses while maintaining price competitiveness. EPS is forecast at 257.5 yen, with a target ROE of 14.5%.

Net Sales Trend (FY2024 to FY2026 Q3)

Operating Income Trend (FY2024 to FY2026 Q3)

Gross Profit Margin Trend (FY2024 to FY2026 Q3)

SG&A Expense Ratio Trend (FY2024 to FY2026 Q3)

Operating Margin Trend (FY2024 to FY2026 Q3)

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Genky DrugStores Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →